Literature DB >> 25700646

[Rare forms of hypertension : From pheochromocytoma to vasculitis].

H Haller1, F Limbourg, B M Schmidt, J Menne.   

Abstract

Secondary hypertension affects only 5-10 % of hypertensive patients. Screening is expensive and time-consuming and should be performed only in patients for whom there is a high clinical suspicion of secondary hypertension. Clinical signs of secondary forms of hypertension are new-onset hypertension in patients without other risk factors (i.e., family history, obesity, etc.), sudden increase of blood pressure (BP) in a previously stable patient, increased BP in prepubertal children, resistant hypertension, and severe hypertension or hypertensive emergencies. In adults, renal parenchymal and vascular diseases as well as obstructive sleep apnea are the most common causes of secondary hypertension. Medication-induced hypertension and non-adherence to medication have to be ruled out. Of the endocrine causes associated with hypertension, primary aldosteronism is the most common. Other endocrine causes of hypertension such as thyroid disease (hypo- or hyperthyroidism), hypercortisolism (Cushing's syndrome), hyperparathyroidism, and pheochromocytoma are rare. Monogenetic forms of hypertension are mostly of tubular origin and associated with alterations in mineralocorticoid handling or signaling. Rare causes of hypertension also include inflammatory vascular disease. Acute forms of vasculitis may present as "malignant" hypertension with associated thrombotic microangiopathy and organ damage/failure. It is important to diagnose these rare forms of hypertension in order to prevent acute organ damage in these patients or unnecessary invasive treatment strategies.

Entities:  

Mesh:

Year:  2015        PMID: 25700646     DOI: 10.1007/s00108-014-3571-1

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  27 in total

Review 1.  Molecular mechanisms of human hypertension.

Authors:  R P Lifton; A G Gharavi; D S Geller
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 2.  Hyperparathyroid and hypoparathyroid disorders.

Authors:  S J Marx
Journal:  N Engl J Med       Date:  2000-12-21       Impact factor: 91.245

3.  Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5.

Authors:  Ute I Scholl; Carol Nelson-Williams; Peng Yue; Roger Grekin; Robert J Wyatt; Michael J Dillon; Robert Couch; Lisa K Hammer; Frances L Harley; Anita Farhi; Wen-Hui Wang; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

4.  A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension.

Authors:  A Odermatt; B Dick; P Arnold; T Zaehner; V Plueschke; M N Deregibus; H Repetto; B M Frey; F J Frey; P Ferrari
Journal:  J Clin Endocrinol Metab       Date:  2001-03       Impact factor: 5.958

5.  A hitherto unreported vascular tumor of the kidney: a proposal of "juxtaglomerular cell tumor".

Authors:  I Kihara; S Kitamura; T Hoshino; H Seida; T Watanabe
Journal:  Acta Pathol Jpn       Date:  1968-05

6.  Hypertension due to a renin-secreting renal tumour.

Authors:  P W Robertson; A Klidjian; L K Harding; G Walters; M R Lee; A H Robb-Smith
Journal:  Am J Med       Date:  1967-12       Impact factor: 4.965

Review 7.  The renal manifestations of thyroid disease.

Authors:  Laura H Mariani; Jeffrey S Berns
Journal:  J Am Soc Nephrol       Date:  2011-10-21       Impact factor: 10.121

8.  K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.

Authors:  Murim Choi; Ute I Scholl; Peng Yue; Peyman Björklund; Bixiao Zhao; Carol Nelson-Williams; Weizhen Ji; Yoonsang Cho; Aniruddh Patel; Clara J Men; Elias Lolis; Max V Wisgerhof; David S Geller; Shrikant Mane; Per Hellman; Gunnar Westin; Göran Åkerström; Wenhui Wang; Tobias Carling; Richard P Lifton
Journal:  Science       Date:  2011-02-11       Impact factor: 47.728

9.  A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension.

Authors:  R P Lifton; R G Dluhy; M Powers; G M Rich; S Cook; S Ulick; J M Lalouel
Journal:  Nature       Date:  1992-01-16       Impact factor: 49.962

10.  A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients.

Authors:  K Hiramatsu; T Yamada; Y Yukimura; I Komiya; K Ichikawa; M Ishihara; H Nagata; T Izumiyama
Journal:  Arch Intern Med       Date:  1981-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.